Director at Affiliated Xiaoshan Hospital, Hangzhou Normal University
Quanfeng Zhu is the Director of the Pharmacy Department at Affiliated Xiaoshan Hospital, Hangzhou Normal University. He specializes in the research of schizophrenia, depression, and other mental disorders. Zhu has played a key role in numerous clinical drug trial programs and provincial and municipal research projects. He is a prolific author, having published dozens of high-quality papers in both domestic and international journals as either the first author or corresponding author.
Profile:
scopus:
Professional Experience:
🔬 Specializes in research on schizophrenia, depression, and other mental illnesses.📝 Leads numerous drug clinical trial programs and provincial/municipal projects.📚 Author of dozens of outstanding papers in domestic and international journals as first or corresponding author.
Research Focus in :
Quanfeng Zhu’s research focus on schizophrenia, depression, and other mental diseases indicates a deep interest in understanding the emotional and cognitive aspects of these conditions. In studying schizophrenia, for example, one may explore how cognitive deficits impact emotional processing and vice versa. Similarly, in depression research, there’s often an examination of how cognitive biases influence emotional experiences and vice versa.
Zhu’s involvement in drug clinical trial programs suggests a practical approach to addressing these conditions, likely aiming to develop interventions that target both emotional and cognitive symptoms. Their publication record indicates a commitment to advancing knowledge in these areas, likely contributing to a deeper understanding of the interplay between emotions and cognition in mental illness.
Citations:
📄 8 documents cited by 8 citations
📑 Author of 8 documents
📊 h-index: 2
Publication Top Notes:
- Correlation analysis and gender differences of cognitive function based on mini-mental state examination (MMSE) and suicidal tendency in patients with schizophrenia
- Authors: Zhu, Q.; Zhang, X.-Y.
- Journal: BMC Psychiatry, 2024, 24(1), 8
- The effect of cognitive impairment based on Mini-Mental State Examination (MMSE) on suicidal tendency in patients with schizophrenia: A large cross-sectional study
- Authors: Zhu, Q.; Jiang, G.; Zheng, Y.; Zhang, P.; Zhang, X.-Y.
- Journal: Schizophrenia Research, 2024, 269, pp. 48–55
- Gender differences in prevalence and clinical risk factors of suicide attempts in young adults with first-episode drug-naive major depressive disorder
- Authors: Zhu, Q.; Lang, X.; Zhang, X.-Y.
- Journal: BJPsych Open, 2024, 10(1), e19
- Altered levels of cytokine, T- and B-lymphocytes, and PD-1 expression rates in drug-naïve schizophrenia patients with acute phase
- Authors: Zheng, Y.; Zhang, Q.; Zhou, X.; Zhu, Q.; Fu, Z.
- Journal: Scientific Reports, 2023, 13(1), 21711
- Prevalence and clinical correlates of abnormal lipid metabolism in first-episode and drug-naïve patients with major depressive disorder with abnormal glucose metabolism
- Authors: Zhu, Q.; Jiang, G.; Lang, X.E.; Zheng, Y.; Zhang, X.
- Journal: Scientific Reports, 2023, 13(1), 8078
- Prevalence and clinical correlates of thyroid dysfunction in first-episode and drug-naïve major depressive disorder patients with metabolic syndrome
- Authors: Zhu, Q.; Jiang, G.; Lang, X.; Zheng, Y.; Zhang, X.-Y.
- Journal: Journal of Affective Disorders, 2023, 341, pp. 35–41
- Prevalence and correlates of dyslipidemia in first-episode and drug-naïve major depressive disorder patients with comorbid abnormal glucose metabolism: Sex differences
- Authors: Zhu, Q.; Zheng, Y.; Lang, X.; Jiang, G.; Zhang, X.
- Journal: Frontiers in Psychiatry, 2023, 14, 1101865
- Identification of immune-related and autophagy-related genes for the prediction of survival in bladder cancer
- Authors: Zhu, Q.; Zhang, L.; Deng, Y.; Tang, L.
- Journal: BMC Genomic Data, 2022, 23(1), 60